ELIOS Vision, Inc. is a private medical device company focused on the commercialization of ELIOS, a proprietary excimer laser treatment for glaucoma. Our goal is to achieve a leadership position within the glaucoma treatment category with a treatment that is proven safe and effective, ‘implant free’ and highly adoptable by physicians. The technique is minimally invasive and can be elegantly combined with routine cataract surgery. ELIOS helps address the needs of >80Mn people worldwide affected by glaucoma. ELIOS is approved for use in EU and is currently undergoing clinical trials for use in the US.